Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3Thoracic 1Gastrointestinal 1

Conditions

Advanced Solid Tumor 2Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors 1

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × glumetinib × Other solid neoplasm × Clear all
NCT06947291 2025-09-08

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 2 Recruiting
350 enrolled
GastrointestinalOther solid neoplasm

Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

NCT03457532 2024-11-01

A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors

Haihe Biopharma Co., Ltd.

Phase 1 Completed
177 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT03466268 2024-10-09

Study to Evaluate the Safety and Anti-tumor Activity of SCC244

Haihe Biopharma Co., Ltd.

Phase 1 Completed
56 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡